The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 23, 2018
Filed:
Sep. 19, 2016
Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
Applicant:
Bone Therapeutics, Gosselies, BE;
Inventors:
Enrico Bastianelli, Rhode-Saint-Genese, BE;
Pierre Attali, Vincennes, FR;
Chris Vervaet, Izegem, BE;
Assignee:
BONE THERAPEUTICS, Gosselies, BE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/00 (2006.01); A61K 31/728 (2006.01); A61K 31/4168 (2006.01); A61K 31/726 (2006.01); A61K 45/06 (2006.01); A61K 47/36 (2006.01); A61K 31/56 (2006.01); A61K 35/12 (2015.01); A61K 35/545 (2015.01); A61M 5/28 (2006.01); A61K 31/573 (2006.01); A61K 35/28 (2015.01); A61K 31/4164 (2006.01); A61K 31/4174 (2006.01); A61K 31/4178 (2006.01);
U.S. Cl.
CPC ...
A61K 31/728 (2013.01); A61K 9/0019 (2013.01); A61K 31/4164 (2013.01); A61K 31/4168 (2013.01); A61K 31/4174 (2013.01); A61K 31/4178 (2013.01); A61K 31/56 (2013.01); A61K 31/573 (2013.01); A61K 31/726 (2013.01); A61K 35/12 (2013.01); A61K 35/28 (2013.01); A61K 35/545 (2013.01); A61K 45/06 (2013.01); A61K 47/36 (2013.01); A61M 5/283 (2013.01);
Abstract
An intra-articular pharmaceutical composition is used for the treatment and/or the prevention of acute or chronic osteoarticular diseases and acute or chronic osteoarticular symptoms especially osteoarthritis. The composition includes a possibly adequate pharmaceutical carrier or diluent, a glycosaminoglycan, a compound activating the alpha 2 adrenergic receptor, an anti-inflammatory agent and stem cells.